Emanuele Puca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

United statesEmanuele pucaAlfredo covelliDario neriSoft tissue sarcomaIndependent dataSafety monitoring boardExperimental armControl armProgression free survivalHazard ratioPress releaseChief medical officerScience translational medicine

Philogen S p A ; Blue Earth Diagnostics: Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philogen S p A ; Blue Earth Diagnostics: Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomStefan klotterDavid gaudenDario neriMike beyerEmanuele pucaBracco groupNational cancer institute of milanItalian stock exchangeSam brown incPhilogen groupFibroblast activation proteinBlue earth diagnosticsEarth diagnosticsBlue earthNational cancer institute

Nidlegy™ Phase III PIVOTAL Trial Meets the Study s Primary Objective Demonstrating Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival for Patients with Locally Advanced Fully Resectable Melanoma

Nidlegy™ Phase III PIVOTAL Trial Meets the Study s Primary Objective Demonstrating Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival for Patients with Locally Advanced Fully Resectable Melanoma
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

New zealandClaus garbeDario neriSun pharmaAbhishek sharmaGaurav chughAlfredo covelliIntratumoral nidlegyEmanuele pucaSun pharmaceutical industries limited reutersSun pharmaceutical industries ltdRecurrence free survivalKorea bizwireSun pharmaceutical industries limitedBlinded independent central reviewInvestigator assessment

Philogen enters into a Service and Supply Agreement with IBSA for the GMP Production of a Therapeutic Protein

Philogen enters into a Service and Supply Agreement with IBSA for the GMP Production of a Therapeutic Protein
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesRosia sienaEmanuele pucaMontarioso sienaDario neriChemical librarySupply agreementServiceand supply agreementMontarioso facilityEuropean countriesAntibody phage display librariesEncoded chemical libraryInstitut biochimique

Philochem and Bracco Imaging Announce a Collaboration on the Development of a Small Molecule for Diagnostic or Medical Imaging Applications

Philochem and Bracco Imaging Announce a Collaboration on the Development of a Small Molecule for Diagnostic or Medical Imaging Applications - read this article along with other careers information, tips and advice on BioSpace

Duccio manettiGiuliano falivaMary jane elliottDavide salviDario neriFulvio renoldi braccoNuclear medicineBracco imaging global communicationsCorporate communicationsItalian stock exchangePhilogen groupConsilium strategic communicationsBracco groupBracco imagingItalian stockComputed tomography